The company received exercise notices from warrant holders to exercise warrants over an aggregate 260,000 shares of common stock, with an exercise price of
Shares in the company closed at
12 May 2016 08:18
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
AKR.L Share News (AKR)
AKR Share
Price
AKR Share
News
AKR Share
Chat
AKR Share
Trades
AKR
Live RNS
AKR Share
Charts
AKR Broker
Ratings
AKR Directors
Deals
AKR Financial
Diary
AKR
Fundamentals
AKR Short
Positions
AKR
Media
AKR.L Information
- There is currently no data for AKR
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)
Fri, 16th Mar 2018 18:11
More News
25 Apr 2016 14:07
Dr Akers steps down as Akers Bioscience chairman
(ShareCast News) - Rapid health information technology developer Akers Biosciences saw its founder and namesake Dr Raymond Akers step down as executive chairman on Monday, instead focusing on the firm's products and research. The AIM-traded company's current non-executive co-chairman, Thomas Knox, w
Read more30 Mar 2016 11:05
23 Mar 2016 16:06
23 Mar 2016 10:24
2 Mar 2016 13:57
Akers Bioscience wins first China order for heparin test
(ShareCast News) - Akers Biosciences has won its first order from Chinese distributor NovoTek Therapeutics, worth $2.5m. The order is for Akers' handheld PIFA heparin allergy tests, which in November gained approval from the China Food and Drug Administration and will be exclusively sold and markete
Read more11 Nov 2015 16:30